Comparison Visfatin level between Obese and Non Obese, Hypertensive and Normotensive patients with Ischemic Heart Disease Al-Kraity Wijdan Rajh Hamza1, Jawad Murtadha M.2 1Department of the Pathological Analysis Techniques, College of Al-Toosi University, Najaf, Iraq 2Technical Institute of AL-Diwaniyah, AL-Furat AL-Awsat Technical University, Najaf, Iraq Corresponding Author E-mail: wijdanrh.sc12p@uokufa.edu.iq, murtadham.alkhafaji@student.uokufa.edu.iq
Online published on 24 December, 2019. Abstract In the current study, seventy of patients who suffering of IHD and the control group was composed of 20 healthy. The samples were collected from the Coronary Care Unit (CCU) in Al-Sadder Teaching Hospital in Al-Najaf province/Iraq, during the period from September till December 2018. The ages of patients and control ranged from 30 to 69 years old. The Patients groups are divided into subgroup according blood pressure and Body mass index. The results of current study revealed significant differences between IHD group and healthy group, significantly increased (p<0.05) in serum visfatin level and W.C., BMI compared with healthy group. The results indicated a significant increased (p<0.05) in serum VF level of hypertensive group compared with normotensive group in IHD patients. The results indicated when compared with different BMI (normal, over, obese and morbid weight) groups of IHD, there was a significant increase (p>0.05) in VF concentration among different BMI. The result indicated positive correlation between BMI, W.C.) and (VF). Conclusion The current study concluded that visfatin level were good marker for detection and diagnosis of ischemic heart disease, and visfatin highly related with risk factors of ischemic heart disease such as hypertensive blood pressure and obesity. Top Keywords Ischemic heart disease, Visfatin, Obesity and Hypertension. Top |